Converge Technology Solutions Gets Shareholder Approval for Acquisition by H.I.G. Capital
April 10, 2025 - 19:32
Converge Technology Solutions Corp. has announced that its shareholders have overwhelmingly approved the acquisition by H.I.G. Capital. This significant decision marks a pivotal moment for the company, which has been focused on expanding its capabilities and market presence. The approval comes after a thorough review process and reflects the shareholders' confidence in the strategic direction of the company under new ownership.
The acquisition is expected to enhance Converge's growth trajectory and provide additional resources to further develop its innovative technology solutions. With H.I.G. Capital's backing, Converge aims to leverage new opportunities in the technology sector, positioning itself for long-term success.
The transaction is anticipated to close in the coming weeks, subject to customary closing conditions. Converge's leadership expressed gratitude to its shareholders for their support and looks forward to embarking on this new chapter. The company remains committed to delivering exceptional value to its clients and stakeholders as it transitions into this new phase of development.
MORE NEWS
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...